Cullimore added that the strategic plans to reposition Dynatronics in a fast-evolving, competitive industry are showing great promise as sales momentum continues to build as does interest on the part of sales reps and dealers to be part of the Dynatronics team.
Dynatronics has scheduled a conference call for investors today, Monday, November 19, 2007, at 1:30 p.m. ET (11:30 a.m. MT). Those wishing to participate should call 800-839-9416 and use passcode 1383812.
A summary of the financial results for the first quarter ended September 30, 2007, follows:
Summary Selected Financial Data
Income Statement Highlights
Three Months Ended
Net sales $7,891,430 $4,139,057
Cost of sales 4,959,118 2,646,900
Gross profit 2,932,312 1,492,157
SG&A expenses 3,575,495 1,261,145
R&D expenses 338,893 478,084
Other expense, net 127,167 37,495
Loss before income taxes (1,109,243) (284,567)
Income tax benefit (397,040) (109,559)
Net loss $ (712,203) $ (175,008)
Net loss per share (diluted) $ (.05) $ (.02)
Dynatronics manufactures, markets and distributes advanced-technology
medical devices, orthopedic soft goods and supplies, treatment tables and
rehabilitation equipment for the physical therapy, sports medicine,
chiropractic, podiatry, plastic surgery, dermatology and other related
medical, cosmetic and aesthetic markets. More information regarding
|SOURCE Dynatronics Corporation|
Copyright©2007 PR Newswire.
All rights reserved